Canada markets closed

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
2,619.30+25.00 (+0.96%)
At close: 03:30PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 445.64B
Enterprise Value 428.64B
Trailing P/E 83.87
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)13.40
Price/Book (mrq)28.82
Enterprise Value/Revenue 12.94
Enterprise Value/EBITDA 53.18

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52-Week Change 387.91%
S&P500 52-Week Change 323.49%
52 Week High 32,650.00
52 Week Low 31,361.85
50-Day Moving Average 32,074.36
200-Day Moving Average 31,875.42

Share Statistics

Avg Vol (3 month) 3184.76k
Avg Vol (10 day) 3319.68k
Shares Outstanding 5169.41M
Implied Shares Outstanding 6170.14M
Float 841.37M
% Held by Insiders 175.58%
% Held by Institutions 19.45%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 432
Forward Annual Dividend Yield 41.22%
Trailing Annual Dividend Rate 332.00
Trailing Annual Dividend Yield 31.23%
5 Year Average Dividend Yield 41.73
Payout Ratio 4102.47%
Dividend Date 3N/A
Ex-Dividend Date 4May 31, 2024
Last Split Factor 22:1
Last Split Date 3Sept 11, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 17.08%
Operating Margin (ttm)25.72%

Management Effectiveness

Return on Assets (ttm)15.24%
Return on Equity (ttm)33.53%

Income Statement

Revenue (ttm)34.54B
Revenue Per Share (ttm)203.90
Quarterly Revenue Growth (yoy)18.10%
Gross Profit (ttm)N/A
EBITDA 9.09B
Net Income Avi to Common (ttm)5.9B
Diluted EPS (ttm)31.17
Quarterly Earnings Growth (yoy)45.80%

Balance Sheet

Total Cash (mrq)18.76B
Total Cash Per Share (mrq)110.76
Total Debt (mrq)186.7M
Total Debt/Equity (mrq)1.05%
Current Ratio (mrq)1.84
Book Value Per Share (mrq)104.93

Cash Flow Statement

Operating Cash Flow (ttm)5.82B
Levered Free Cash Flow (ttm)6.78B